Mechanism of Gamma-glutamyl Transpeptidase Release in Serum During Intrahepatic and Extrahepatic Cholestasis in the Rat: a Histochemical, Biochemical and Molecular Approach
Overview
Affiliations
The mechanism of the elevation of serum gamma-glutamyl transpeptidase activity in cholestasis is not clear. We therefore analyzed rat gamma-glutamyl transpeptidase activities in liver, bile and serum during intrahepatic cholestasis induced by a single dose of alpha-naphthyl isothiocyanate (20 mg/100 gm body weight) and during extrahepatic cholestasis after bile duct ligation. At days 1 and 2 after alpha-naphthyl isothiocyanate ingestion, we saw a fivefold and a 60-fold increase in serum and bile gamma-glutamyl transpeptidase activities, respectively. These increases were associated with a decrease in hepatic gamma-glutamyl transpeptidase activity and of corresponding mRNA. Simultaneously, necrosis of the biliary epithelium appeared in portal tracts. From day 2 to day 14, gamma-glutamyl transpeptidase activity in bile and serum progressively returned to basal levels; in the liver, cholangiolar proliferation was mild and was associated with moderate elevation of the gamma-glutamyl transpeptidase activity and of its corresponding mRNA. In extrahepatic cholestasis, a 10-fold increase in serum gamma-glutamyl transpeptidase activity was detected between day 0 and day 14. This increase was associated with major cholangiolar proliferation and with a progressive rise in hepatic gamma-glutamyl transpeptidase activity and in specific mRNA; in bile, gamma-glutamyl transpeptidase activity was slightly elevated. In these two models of cholestasis, histochemically detected gamma-glutamyl transpeptidase activity was largely predominant in biliary cells. We found no significant induction of gamma-glutamyl transpeptidase activity in hepatocytes. These results suggest that in these two models of cholestasis, the increase in serum gamma-glutamyl transpeptidase activity is of biliary cell origin and does not originate from hepatocytes.(ABSTRACT TRUNCATED AT 250 WORDS)
Shetty M, Shenoy S, Amuthan A, Devi V, Kumar N, Kiran A F1000Res. 2025; 13:639.
PMID: 39916986 PMC: 11800331. DOI: 10.12688/f1000research.145961.2.
Kohlmaier B, Tichy H, Blatterer J, Till H, Schlagenhauf A, Knisely A JPGN Rep. 2024; 5(4):533-537.
PMID: 39610416 PMC: 11600354. DOI: 10.1002/jpr3.12131.
Li J, Zhan D, Chen C, Li R, Zhu F Korean J Physiol Pharmacol. 2024; 28(6):539-547.
PMID: 39467717 PMC: 11519720. DOI: 10.4196/kjpp.2024.28.6.539.
Autoantibodes to GP210 are a metric for UDCA responses in primary biliary cholangitis.
Wang C, Qin Z, Zhang M, Dai Y, Zhang L, Tian W J Transl Autoimmun. 2024; 8:100239.
PMID: 38550612 PMC: 10973586. DOI: 10.1016/j.jtauto.2024.100239.
Cabibi D, Giannone A, Quattrocchi A, Calvaruso V, Porcasi R, Di Grusa D Biomedicines. 2024; 12(2).
PMID: 38398042 PMC: 10887071. DOI: 10.3390/biomedicines12020440.